Cargando…

Pulmonary arterial remodeling induced by a Th2 immune response

Pulmonary arterial remodeling characterized by increased vascular smooth muscle density is a common lesion seen in pulmonary arterial hypertension (PAH), a deadly condition. Clinical correlation studies have suggested an immune pathogenesis of pulmonary arterial remodeling, but experimental proof ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daley, Eleen, Emson, Claire, Guignabert, Christophe, de Waal Malefyt, Rene, Louten, Jennifer, Kurup, Viswanath P., Hogaboam, Cory, Taraseviciene-Stewart, Laimute, Voelkel, Norbert F., Rabinovitch, Marlene, Grunig, Ekkehard, Grunig, Gabriele
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2008
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2271018/ https://www.ncbi.nlm.nih.gov/pubmed/18227220 http://dx.doi.org/10.1084/jem.20071008

Ejemplares similares

Interleukin-19: A Constituent of the Regulome That Controls Antigen Presenting Cells in the Lungs and Airway Responses to Microbial Products
por: Hoffman, Carol, et al.
Publicado: (2011)

Acrolein Induces Endoplasmic Reticulum Stress and Causes Airspace Enlargement
por: Kitaguchi, Yoshiaki, et al.
Publicado: (2012)

Second hand smoke and COPD: lessons from animal studies
por: Borchers, Michael T., et al.
Publicado: (2014)

Tobacco smoke induced COPD/emphysema in the animal model—are we all on the same page?
por: Leberl, Maike, et al.
Publicado: (2013)

Imaging the heart in pulmonary hypertension: an update
por: Grünig, Ekkehard, et al.
Publicado: (2015)

Interleukin-10 Is a Natural Suppressor of Cytokine Production and Inflammation in a Murine Model of Allergic Bronchopulmonary Aspergillosis
por: Grünig, Gabriele, et al.
Publicado: (1997)

Biomarkers of Disease and Treatment in Murine and Cynomolgus Models of Chronic Asthma
por: Louten, Jennifer, et al.
Publicado: (2012)

Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention
por: Grunig, Gabriele, et al.
Publicado: (2018)

Immunomodulatory strategies prevent the development of autoimmune emphysema
por: Hanaoka, Masayuki, et al.
Publicado: (2010)

Right Heart Size and Right Ventricular Reserve in Pulmonary Hypertension: Impact on Management and Prognosis
por: Grünig, Ekkehard, et al.
Publicado: (2020)

Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study
por: Ulrich, Silvia, et al.
Publicado: (2008)

An Emotional Molecular Pathway in Pulmonary Hypertension–Alternative Complement System
por: Grunig, Gabriele, et al.
Publicado: (2020)

Practical management of riociguat in patients with pulmonary arterial hypertension
por: Halank, Michael, et al.
Publicado: (2019)

Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs
por: Grunig, Gabriele, et al.
Publicado: (2016)

Resistin-like Molecule α and Pulmonary Vascular Remodeling: A Multi-Strain Murine Model of Antigen and Urban Ambient Particulate Matter Co-Exposure
por: Durmus, Nedim, et al.
Publicado: (2023)

Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension
por: Pfarr, Nicole, et al.
Publicado: (2013)

Dirección de relaciones públicas
por: Grunig, James E.
Publicado: (2000)

Correction: Elevated microRNA-135a is associated with pulmonary arterial hypertension in experimental mouse model
por: Lee, Hyun-Wook, et al.
Publicado: (2017)

EIF2AK4 mutation as “second hit” in hereditary pulmonary arterial hypertension
por: Eichstaedt, Christina A., et al.
Publicado: (2016)

BMPR2 Promoter Variants Effect Gene Expression in Pulmonary Arterial Hypertension Patients
por: Song, Jie, et al.
Publicado: (2020)

The effect of exercise training and physiotherapy on left and right heart function in heart failure with preserved ejection fraction: a systematic literature review
por: Palevičiūtė, Eglė, et al.
Publicado: (2022)

Mutation in BMPR2 Promoter: A ‘Second Hit’ for Manifestation of Pulmonary Arterial Hypertension?
por: Viales, Rebecca Rodríguez, et al.
Publicado: (2015)

Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells
por: Grünig, David, et al.
Publicado: (2018)

N-Terminal Pro-Brain Natriuretic Peptide Is a Useful Prognostic Marker in Patients with Pre-Capillary Pulmonary Hypertension and Renal Insufficiency
por: Harbaum, Lars, et al.
Publicado: (2014)

Identification of a New Intronic BMPR2-Mutation and Early Diagnosis of Heritable Pulmonary Arterial Hypertension in a Large Family with Mean Clinical Follow-Up of 12 Years
por: Hinderhofer, Katrin, et al.
Publicado: (2014)

Diagnostic accuracy of automated 3D volumetry of cardiac chambers by CT pulmonary angiography for identification of pulmonary hypertension due to left heart disease
por: Melzig, Claudius, et al.
Publicado: (2022)

A Computational Growth and Remodeling Framework for Adaptive and Maladaptive Pulmonary Arterial Hemodynamics
por: Szafron, Jason M., et al.
Publicado: (2023)

Mutually reinforcing effects of genetic variants and interferon-β 1a therapy for pulmonary arterial hypertension development in multiple sclerosis patients
por: Lerche, Marianne, et al.
Publicado: (2019)

Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis
por: Xanthouli, Panagiota, et al.
Publicado: (2022)

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH
por: Gall, Henning, et al.
Publicado: (2018)

Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri(®)): a prospective, 6-months, open label, observational, non-interventional study
por: Degering, Julia, et al.
Publicado: (2023)

Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial
por: Palevičiūtė, Eglė, et al.
Publicado: (2023)

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
por: Humbert, Marc, et al.
Publicado: (2019)

Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
por: Nagel, Christian, et al.
Publicado: (2015)

Right heart size and function significantly correlate in patients with pulmonary arterial hypertension – a cross-sectional study
por: Fischer, Lukas, et al.
Publicado: (2018)

Diagnosis of Swimming Induced Pulmonary Edema—A Review
por: Grünig, Hannes, et al.
Publicado: (2017)

Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up
por: Xanthouli, Panagiota, et al.
Publicado: (2020)

Pulmonary arterial wedge pressure increase during exercise in patients diagnosed with pulmonary arterial or chronic thromboembolic pulmonary hypertension
por: Müller, Julian, et al.
Publicado: (2023)

New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis
por: Nicolls, Mark R., et al.
Publicado: (2012)

Modification of Hemodynamic and Immune Responses to Exposure with a Weak Antigen by the Expression of a Hypomorphic BMPR2 Gene
por: Park, Sung-Hyun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e237sn9eattid9nc5v977e3g85